@article{17d84d2e5da74284b9006b6dfec36125,
title = "Biosimilars and drug development in allergic and immunologic diseases",
abstract = "...",
keywords = "Allergic, Animals, Anti-Allergic Agents, Antirheumatic Agents, Biological Products, Biosimilar Pharmaceuticals, Drug Development, Drugs, Generic, Europe, Humans, Hypersensitivity, Immune System Diseases, Immunology, Immunology and Allergy, United States, biologics, Allergic, Animals, Anti-Allergic Agents, Antirheumatic Agents, Biological Products, Biosimilar Pharmaceuticals, Drug Development, Drugs, Generic, Europe, Humans, Hypersensitivity, Immune System Diseases, Immunology, Immunology and Allergy, United States, biologics",
author = "Matteo Bonini and Sergio Bonini",
year = "2017",
doi = "10.1016/j.jaci.2017.03.008",
language = "English",
volume = "139",
pages = "1461--1464",
journal = "JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY",
issn = "0091-6749",
publisher = "Mosby Year Book Incorporated:6277 Sea Harbor Drive:Orlando, FL 32887:(800)654-2452, (407)345-4000, EMAIL: hhspcs@harcourt.com, INTERNET: http://www.mosby.com, Fax: (407)363-9661, (314)432-1380",
}